Sciatica is one of the most commonly mismanaged conditions in primary care. People arrive at their GP or emergency department in genuine, sometimes debilitating pain — often after being told they have a bulging disc — and leave with a script for anti-inflammatories, instructions to rest, and a referral for imaging that, in most cases, changes nothing about their treatment. For a lot of people, that's where the effective care stops.
The problem is not lack of research. The problem is that the research is routinely ignored. We know — clearly and consistently, across multiple clinical guidelines and systematic reviews — that sciatica responds best to graded active rehabilitation, that prolonged rest is harmful, and that the relationship between disc imaging findings and pain is far weaker than most people assume. So let's look at what the science actually says.
What Sciatica Actually Is (and Isn't)
Sciatica is not a diagnosis. It is a symptom — specifically, pain that radiates along the distribution of the sciatic nerve, which exits the lumbar spine via the nerve roots of L4, L5, S1, S2, and S3, passes through the buttock, and travels down the back of the leg to the foot. The character of that pain varies: it can be sharp, burning, shooting, or a deep ache, and is typically accompanied by paresthesia (tingling or numbness) in the relevant dermatome.1
The underlying cause in the majority of cases is lumbar disc herniation with nerve root involvement — typically at the L4/5 or L5/S1 level. Koes, van Tulder, and Peul, writing in the BMJ in 2007, estimated that disc herniation accounts for approximately 90% of sciatica cases, with the remainder arising from lumbar spinal stenosis, spondylolisthesis, or, far less commonly, pathological causes such as tumour or infection.2 A useful clinical rule: true sciatica from nerve root irritation produces pain that is worse in the leg than in the back. If the back pain predominates, the picture is different.
The Anatomy: Why Chemical Irritation Matters More Than Mechanical Compression
There is a widely held assumption that sciatica is simply about a disc pushing on a nerve. The mechanical compression model is not wrong, but it is incomplete — and the incompleteness explains why many people with confirmed disc herniation have no pain, and why some people with minimal disc changes have severe symptoms.
When the outer annulus fibrosus of a disc tears and nucleus pulposus material is extruded, it does two things: it can apply direct mechanical pressure to the adjacent nerve root, and — critically — it releases phospholipase A2, prostaglandins, and inflammatory cytokines that chemically irritate the nerve root and the surrounding tissues. Ropper and Zafonte, reviewing the pathophysiology in the New England Journal of Medicine, describe the inflammatory cascade as a primary driver of the intense, early-phase pain in disc-related sciatica, noting that the severity of pain correlates poorly with the size of the disc herniation on imaging.3
This explains why some disc herniations are extremely painful and others are incidental imaging findings. The tissue injury alone is not the pain — the nervous system's response to that injury is.
Important for clinical management: Deyo and Mirza, also writing in the New England Journal of Medicine (2016), reviewed the evidence on lumbar disc herniation and noted that most extruded disc fragments undergo spontaneous resorption over weeks to months — particularly large herniations with significant extrusion. This biological resorption partially explains the favourable natural history of many sciatica cases when managed conservatively with active rehabilitation rather than early surgery.4
Why Pain Persists: Central Sensitisation and the Nervous System's Role
In acute sciatica, the pain signal makes sense — there is an irritated nerve root generating nociceptive input. But in persistent sciatica lasting beyond 3–6 months, the original tissue source often ceases to be the primary driver of symptoms. What takes over is a process called central sensitisation: a state of heightened excitability in the central nervous system where the pain-processing circuitry becomes amplified, producing pain that is disproportionate to the remaining tissue state.
Konstantinou and Dunn's 2008 review in Spine, synthesising epidemiological data from multiple countries, found that approximately 40% of people with sciatica at 1 year continued to report significant pain and disability — a rate substantially higher than the disc herniation's natural history would predict, suggesting that in a significant subset, central mechanisms had become dominant.5
Vlaeyen and Linton's foundational work on the fear-avoidance model — reviewed and updated in Pain in 2012 — provides a complementary explanation. When pain from sciatica generates fear of movement (kinesiophobia), patients restrict activity, avoid positions that previously caused pain, and adopt protective movement patterns. These avoidance behaviours reduce physical capacity, increase pain sensitivity over time, and are strongly associated with the development of chronic pain — independent of the degree of nerve root involvement.6
Primary structural source. Mechanical compression and chemical irritation of the nerve root. Most important in the acute phase.
Phospholipase A2 and cytokine release sensitise the nerve root independent of mechanical pressure. Explains pain severity beyond disc size.
Amplification of the pain signal within the CNS. Becomes increasingly important after 3–6 months of persistent symptoms.
Protective movement restriction reduces capacity and perpetuates sensitisation. A primary driver of chronicity regardless of tissue state.
The Neurodynamics Framework: Jesson, Schmid, and Coppieters
One of the most clinically useful frameworks for understanding and treating sciatica — and one that remains underused in primary care — is neurodynamics: the study of how neural tissue moves, adapts, and responds to mechanical loading. Healthy nerves require freedom of movement relative to surrounding structures. They slide, tension, and adapt to posture and movement continuously. When a nerve root is inflamed or compressed, its mechanical properties change — it becomes stiffer, more sensitive to load, and less tolerant of the positions that previously caused no issue.
Jesson, Runge, and Schmid, in their 2022 review published in Pain Reports, examined the evidence for physiotherapy interventions in painful peripheral neuropathies, including nerve root conditions. Their analysis highlighted that nerve-targeted interventions — particularly graded neurodynamic mobilisation — produced clinically meaningful improvements in pain and function, with the most robust evidence for techniques that progressively restore the nerve's mechanical tolerance rather than avoiding provocative positions entirely.7 The review emphasised that the goal is not to avoid loading the nervous system but to appropriately manage and progressively expand its loading capacity.
Schmid, Nee, and Coppieters, in their important 2013 paper in Manual Therapy, reappraised entrapment neuropathies from a mechanobiological perspective, describing how sustained mechanical deformation of peripheral nerves alters intraneural blood flow, causes localised ischaemia, and ultimately leads to altered axonal transport — processes that explain why position-sustained nerve loading (such as prolonged sitting in lumbar flexion) consistently aggravates sciatica symptoms, and why restoring normal neural mobility is a primary treatment goal.8
Coppieters and Butler's detailed 2008 analysis in Manual Therapy of neurodynamic techniques distinguished between 'slider' techniques — which move the nerve relative to surrounding tissue without sustained tension — and 'tensioner' techniques, which apply and sustain neural tension. Their biomechanical modelling suggested that slider techniques generate substantially less intraneural pressure and are therefore better tolerated in acute, highly sensitised presentations, while tensioner progressions are appropriate as tolerance improves.9
Clinical application: In practice, this means the first priority in acute sciatica is reducing neural sensitivity through gentle, non-provocative movement — not aggressive stretching or high-load spinal exercises. As sensitivity decreases, loading is progressively increased. The goal is not symptom elimination before movement, but controlled re-exposure of the nervous system to movement and load.
What the Evidence Says About Treatment
Jensen, Kongsted, Kjaer, and Koes, in their 2019 update in the BMJ, summarised the current evidence for sciatica management across modalities. Their key findings are consistent with those of other major guidelines: active rehabilitation is superior to passive treatment; NSAIDs provide modest short-term pain reduction but no effect on recovery speed; opioids are not recommended; and the evidence for corticosteroid injections shows, at best, 2–4 weeks of modest pain reduction with no effect on disability, return to work, or long-term outcomes.10
What does work — and what is supported by the highest-quality evidence — is a combination of: patient education about the nature of sciatica and the favourable natural history; progressive exercise including neurodynamic mobilisation; graded return to activity; and, where fear-avoidance is present, targeted cognitive approaches to reduce protective behaviour. Nee and Butler's foundational 2006 paper in Physical Therapy in Sport argued that integrating neurobiology and neurodynamics into clinical management is not merely an add-on but a prerequisite for effective treatment of nerve-related pain.11
The Role of Imaging: Why Your MRI Might Not Mean What You Think
Disc abnormalities on MRI are extremely common in the adult population with no symptoms at all. A widely cited systematic review established that disc bulges are present in approximately 30% of asymptomatic 20-year-olds, rising to over 60% in those over 50. The clinical implication is important: an MRI finding of disc herniation at a level that corresponds with your symptoms is corroborating evidence — it is not a diagnosis on its own, and it does not determine the appropriate management.
Bardin, King, and Maher's 2017 clinical guide in the Medical Journal of Australia recommends that imaging for low back pain and sciatica should be reserved for cases where a specific serious pathology (red flags) is suspected, or where management would change based on the result — neither of which is true in the vast majority of presentations.12 Routine early imaging in non-specific sciatica does not improve outcomes, increases healthcare costs, and — critically — increases the risk of unnecessary intervention by identifying incidental findings that may not be contributing to symptoms.
Prognosis and Why Active Management Matters Early
The natural history of acute sciatica is generally favourable: most people with disc-related nerve root pain see significant improvement within 6–12 weeks. But this recovery is not unconditional. It is most likely in people who remain as active as symptoms permit, who understand the nature of their condition, and who do not develop the fear-avoidance patterns associated with chronicity.
The evidence is clear that the way sciatica is managed in its early stages matters enormously for long-term outcomes. Passive approaches — prolonged rest, repeated passive treatments, heavy reliance on analgesia — increase the risk of transitioning from acute to chronic pain by reinforcing the message that the spine is fragile and movement is dangerous. Active management communicates the opposite: that the nervous system can recover its normal tolerance, that movement is safe and necessary, and that recovery is the expected outcome.
Dealing with sciatica or nerve pain down the leg?
A thorough assessment distinguishes between disc-related nerve root involvement, piriformis syndrome, and other sources of referred leg pain — and determines the right approach from day one. Book at Kenmore or Jindalee.
- Ropper AH, Zafonte RD. Sciatica. New England Journal of Medicine. 2015;372(13):1240–1248.
- Koes BW, van Tulder M, Peul W. Diagnosis and treatment of sciatica. BMJ. 2007;334(7607):1313–1317.
- Ropper AH, Zafonte RD. Ibid. Pathophysiology section: chemical inflammation in disc herniation.
- Deyo RA, Mirza SK. Herniated lumbar intervertebral disk. New England Journal of Medicine. 2016;374(18):1763–1772.
- Konstantinou K, Dunn KM. Sciatica: review of epidemiological studies and prevalence estimates. Spine. 2008;33(22):2464–2472.
- Vlaeyen JWS, Linton SJ. Fear-avoidance model of chronic musculoskeletal pain: 12 years on. Pain. 2012;153(6):1144–1147.
- Jesson T, Runge N, Schmid AB. Physiotherapy for people with painful peripheral neuropathies: a narrative review of its efficacy and safety. Pain Reports. 2022;7(5):e1018.
- Schmid AB, Nee RJ, Coppieters MW. Reappraising entrapment neuropathies — mechanisms, diagnosis and management. Manual Therapy. 2013;18(6):449–457.
- Coppieters MW, Butler DS. Do 'sliders' slide and 'tensioners' tension? An analysis of neurodynamic techniques and considerations regarding their application. Manual Therapy. 2008;13(3):213–221.
- Jensen RK, Kongsted A, Kjaer P, Koes B. Diagnosis and treatment of sciatica. BMJ. 2019;367:l6273.
- Nee RJ, Butler D. Management of peripheral neuropathic pain: integrating neurobiology, neurodynamics, and clinical evidence. Physical Therapy in Sport. 2006;7(1):36–49.
- Bardin LD, King P, Maher CG. Diagnostic triage for low back pain: a practical guide for primary care. Medical Journal of Australia. 2017;206(6):268–273.